US4824432A
(en)
*
|
1981-03-24 |
1989-04-25 |
S.V.S. Laboratories, Inc. |
Method for treating AIDS and other immune deficiencies and immune disorders
|
US5130128A
(en)
*
|
1982-06-03 |
1992-07-14 |
Stolle Research & Development Corporation |
Use of honey as vaccine
|
US5853765A
(en)
*
|
1982-06-03 |
1998-12-29 |
Dcv, Inc. |
Anti-cholesterolemic egg, vaccine and method for production, and use
|
CH0225254H1
(en)
*
|
1985-11-25 |
1998-09-15 |
Ghen Corp |
Specific antibody-containing substance from eggs and method of production and use thereof
|
CA1336818C
(en)
*
|
1987-04-16 |
1995-08-29 |
International Institute Of Cellular And Molecular Pathology |
Treatment of allergy and composition thereof
|
US5284931A
(en)
*
|
1987-05-04 |
1994-02-08 |
Dana Farber Cancer Institute |
Intercellular adhesion molecules, and their binding ligands
|
US5565550A
(en)
*
|
1987-05-04 |
1996-10-15 |
Dana Farber Cancer Institute |
Antibodies to ICAM-2, and fragments thereof
|
JP2641228B2
(ja)
*
|
1988-01-22 |
1997-08-13 |
鐘紡株式会社 |
抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
|
US5059419A
(en)
*
|
1988-06-09 |
1991-10-22 |
Grand Laboratories, Inc. |
Streptococcus suis antiserum and its use in treating Streptococcus suis infections
|
JP2689511B2
(ja)
*
|
1988-08-18 |
1997-12-10 |
ライオン株式会社 |
食 品
|
US6511664B1
(en)
|
1989-03-09 |
2003-01-28 |
Dana Farber Cancer Institute |
Intercellular adhesion molecule—2 and its binding ligands
|
DE3924746A1
(de)
*
|
1989-07-26 |
1991-01-31 |
Behringwerke Ag |
Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
|
US6932968B1
(en)
|
1989-07-26 |
2005-08-23 |
Dade Behring Marburg Gmbh |
Erythropoietin (EPO) peptides and antibodies directed against these
|
US7005560B1
(en)
*
|
1989-10-27 |
2006-02-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
US5196193A
(en)
*
|
1989-10-31 |
1993-03-23 |
Ophidian Pharmaceuticals, Inc. |
Antivenoms and methods for making antivenoms
|
US5601823A
(en)
*
|
1989-10-31 |
1997-02-11 |
Ophidian Pharmaceuticals, Inc. |
Avian antitoxins to clostridium difficle toxin A
|
US5958413A
(en)
*
|
1990-11-01 |
1999-09-28 |
Celltech Limited |
Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
|
US5753228A
(en)
*
|
1992-08-25 |
1998-05-19 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
|
JP2553445B2
(ja)
*
|
1992-12-17 |
1996-11-13 |
同仁医薬化工株式会社 |
抗体の安定化方法
|
BR9307851A
(pt)
*
|
1993-05-26 |
1996-03-19 |
Stolle Res & Dev |
Ovo anti-colesterolêmico vacina e processo para sua produção e uso
|
US6068862A
(en)
*
|
1993-06-30 |
2000-05-30 |
Taiyo Kagaku Co., Ltd. |
Tea-derived feed additive and animal feed containing the same
|
WO1995019570A1
(en)
*
|
1994-01-14 |
1995-07-20 |
Genentech, Inc. |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
US5830479A
(en)
*
|
1994-02-09 |
1998-11-03 |
Willmar Poultry Company, Inc. |
Active immunization using a siderophore receptor protein
|
EP0749321B1
(en)
*
|
1994-02-09 |
2007-01-24 |
Epitopix LLC |
Active immunization using a siderophore receptor protein
|
US5538733A
(en)
*
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
US5814316A
(en)
*
|
1994-08-05 |
1998-09-29 |
Wisconsin Alumni Research Foundation |
Compound to mimick a naturally occurring peptide's effect
|
JP3884069B2
(ja)
*
|
1994-08-05 |
2007-02-21 |
ウィスコンシン アルムニ リサーチ ファウンデーション |
給餌効率を向上させるために使用されるcck抗体
|
US5939269A
(en)
*
|
1994-12-28 |
1999-08-17 |
The Regents Of The University Of California |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
AU5431196A
(en)
*
|
1995-03-24 |
1996-10-16 |
Ophidian Pharmaceuticals |
Treatment for verotoxin-producing escherichia coli
|
FI955389A0
(fi)
*
|
1995-11-09 |
1995-11-09 |
Antti Sakari Aaltonen |
Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
|
ATE266676T1
(de)
*
|
1996-03-12 |
2004-05-15 |
Ovogenix Immunpharma Gmbh |
Verwendung von aviären, vitellinen, gegen hiv- antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
|
US5807551A
(en)
*
|
1996-04-01 |
1998-09-15 |
Iowa State University Research Foundation, Inc. |
Method to provide artificial passive immunity in birds
|
US5725873A
(en)
*
|
1996-07-22 |
1998-03-10 |
Wisconsin Alumni Research Foundation |
Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
|
US5772999A
(en)
*
|
1996-07-30 |
1998-06-30 |
Dcv Biologics, L.P. |
Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
|
EP0930891A4
(en)
*
|
1996-10-02 |
2001-07-04 |
Ovimmune Inc |
ORAL ADMINISTRATION OF CHICKEN EGG ANTIBODIES FOR TREATING DISEASES
|
JP3430853B2
(ja)
|
1997-04-11 |
2003-07-28 |
株式会社ゲン・コーポレーション |
胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
|
JPH10298105A
(ja)
*
|
1997-04-23 |
1998-11-10 |
Gen Corp:Kk |
腸管出血性大腸菌による感染症の予防剤および治療剤
|
AU7712598A
(en)
*
|
1997-06-04 |
1998-12-21 |
Regents of The University of Arizona, The |
Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
|
US6086878A
(en)
*
|
1997-08-21 |
2000-07-11 |
Dcv, Inc. |
Method of increasing muscle protein and reducing fat in animals
|
CZ287956B6
(cs)
*
|
1997-11-04 |
2001-03-14 |
Medipharm Cz, S. R. O. |
Perorální přípravek k prevenci a léčbě parvovirózy psů
|
US6395273B1
(en)
*
|
1998-06-10 |
2002-05-28 |
Promega Corporation |
Prevention and treatment of inflammatory bowel disease
|
JP2000351735A
(ja)
*
|
1999-04-09 |
2000-12-19 |
Akzo Nobel Nv |
カンピロバクターワクチン
|
US7241443B1
(en)
*
|
1999-07-15 |
2007-07-10 |
Camas Incorporated |
Immunogen adherence inhibitor and method of making and using same
|
US7238351B2
(en)
*
|
1999-07-15 |
2007-07-03 |
Peter Nash |
Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
|
AU6726500A
(en)
*
|
1999-08-24 |
2001-03-19 |
Nomoto, Kikuo |
Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof
|
US6706267B1
(en)
*
|
1999-09-14 |
2004-03-16 |
Arkion Life Sciences Llc |
Glucosamine and egg for reducing inflammation
|
AU2001249388A1
(en)
*
|
2000-03-24 |
2001-10-08 |
Trouw Nutrition Usa |
Combination of plasma and hyperimmunized products for increased performance
|
MXPA03006038A
(es)
|
2001-01-03 |
2005-02-14 |
Willmar Poultry Co Inc |
Composiciones inmunizantes y metodos de uso.
|
CA2339436A1
(fr)
|
2001-03-15 |
2002-09-15 |
Josee Harel |
Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
|
WO2002094124A2
(en)
*
|
2001-05-18 |
2002-11-28 |
Arkion Life Sciences |
Method of increasing uniformity in avians
|
US20030003104A1
(en)
*
|
2001-07-02 |
2003-01-02 |
John Mottola |
Method for removal of pathogens from a localized environment
|
US6770280B1
(en)
|
2001-11-15 |
2004-08-03 |
Humanetics Corporation |
Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
|
JP2006504393A
(ja)
*
|
2001-12-28 |
2006-02-09 |
カマス インコーポレイテッド |
免疫抗原付着剤とその製造及び使用方法
|
KR100489615B1
(ko)
*
|
2002-01-30 |
2005-05-17 |
주식회사 단바이오텍 |
리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
|
KR20040105710A
(ko)
*
|
2002-02-11 |
2004-12-16 |
아르키온 라이프 사이언씨즈 엘엘씨 |
정제된 사이토킨 억제인자
|
US20040005327A1
(en)
*
|
2002-05-16 |
2004-01-08 |
Subramanian Iyer |
Immune T-cell stimulation
|
US6729265B2
(en)
*
|
2002-06-27 |
2004-05-04 |
Arkion Life Sciences Llc |
Supplemented antibody feed to enter the circulating system of newborns
|
US9701737B2
(en)
*
|
2003-02-19 |
2017-07-11 |
Camas, Incorporated |
Immunogen adherence and method of making and using same
|
ES2371395T3
(es)
*
|
2003-02-19 |
2011-12-30 |
Camas Incorporated |
Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo.
|
BR0318333A
(pt)
*
|
2003-07-07 |
2006-07-11 |
Luiz Fernando Mesquita |
processo de obtenção de complexo liofilizado a partir de segregado extraìdo da glándula de mamìferos, seu uso no tratamento de imunodeficiências e método de tratamento
|
AU2004274977B2
(en)
|
2003-09-19 |
2011-06-23 |
Epitopix, Llc |
Campylobacter polypeptides and methods of use
|
CA2561800C
(en)
*
|
2004-04-16 |
2011-10-18 |
The Governors Of The University Of Alberta |
Anti-gluten egg yolk antibodies for the treatment of celiac disease
|
US8877187B2
(en)
*
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
WO2007027321A2
(en)
*
|
2005-07-25 |
2007-03-08 |
Avianax, Inc. |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
US20070264264A1
(en)
*
|
2005-08-30 |
2007-11-15 |
La Belle Associates, Inc. |
Method and composition for conferring immunity in mammals
|
CA2521156A1
(en)
*
|
2005-09-16 |
2007-03-16 |
John Hare |
Antibodies as growth promoting agents
|
EP1790358A1
(en)
*
|
2005-11-23 |
2007-05-30 |
Université de Reims Champagne-Ardennes |
Protein constructs designed for targeting and lysis of cells
|
EP2368569A3
(en)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
JP4753808B2
(ja)
*
|
2006-06-20 |
2011-08-24 |
アサマ化成株式会社 |
感染症予防食品添加用組成物
|
WO2008036682A2
(en)
|
2006-09-18 |
2008-03-27 |
Raptor Pharmaceutical Inc. |
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
|
US8282928B2
(en)
*
|
2007-05-30 |
2012-10-09 |
The Governors Of The University Of Alberta |
Anti-gluten egg yolk antibodies for the treatment of celiac disease
|
CN104642743A
(zh)
|
2007-07-09 |
2015-05-27 |
雀巢产品技术援助有限公司 |
减轻因环境过敏原导致的过敏症的方法
|
WO2009029831A1
(en)
|
2007-08-31 |
2009-03-05 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
WO2010028072A2
(en)
*
|
2008-09-02 |
2010-03-11 |
Huan Nguyen |
Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
SI2414387T1
(sl)
|
2009-04-03 |
2016-01-29 |
University Of Chicago |
KOMPOZICIJE IN POSTOPKI, POVEZANI Z VARIANTAMI PROTEINA A (SpA)
|
WO2011127032A1
(en)
|
2010-04-05 |
2011-10-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
|
AU2010243205B2
(en)
|
2009-04-27 |
2014-09-11 |
Hadasit Medical Research Services & Development Limited |
Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
|
US10266585B2
(en)
|
2009-08-28 |
2019-04-23 |
The Board Of Regents Of The Univerity Of Texas System |
Methods of treating brain injury
|
BR112012028315A2
(pt)
*
|
2010-05-07 |
2016-10-25 |
Camas Inc |
"composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença".
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
ES2628032T3
(es)
|
2010-08-17 |
2017-08-01 |
Immuron Limited |
Preparación de inmunoglobulina enriquecida con anti-LPS para su uso en el tratamiento y/o la profilaxis de un trastorno patológico
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
EA034057B1
(ru)
*
|
2010-11-23 |
2019-12-23 |
Пантерикс, Инк. |
Способ сокращения продолжительности диареи, вызванной кишечной инфекцией
|
DE102011006781A1
(de)
*
|
2011-04-05 |
2012-10-11 |
Mat-Malta Advanced Technologies Limited |
Antikörperprodukt, umfassend n spezifische Antikörper
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
BR112014003315A2
(pt)
|
2011-08-15 |
2017-03-01 |
Univ Chicago |
composições e métodos relacionados a anticorpos para a proteína a estafilocócica
|
AU2013252888B2
(en)
|
2012-04-26 |
2018-06-14 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
|
WO2013162746A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
CA2909636C
(en)
|
2013-04-19 |
2023-08-22 |
Dena Lyras |
Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease
|
US10716850B2
(en)
|
2014-12-31 |
2020-07-21 |
Wellin, Inc. |
Anti-inflammatory factor retentate, method of isolation, and use
|
WO2017173398A1
(en)
|
2016-04-01 |
2017-10-05 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
US10166280B2
(en)
|
2016-06-08 |
2019-01-01 |
Epitopix, Llc |
Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
|
WO2019183500A1
(en)
|
2018-03-23 |
2019-09-26 |
Hung Chiung Yu |
Coccidioides antigens and methods of their use
|
US11339387B2
(en)
|
2018-05-22 |
2022-05-24 |
The Government Of The United States Of America As Represented By The Secretary Of Homeland Security |
Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
|
US11701423B2
(en)
|
2021-03-12 |
2023-07-18 |
Lay Sciences, Inc. |
Hyperimmunized egg product for treatment or prevention of coronavirus infection
|
JP2024518188A
(ja)
|
2021-05-17 |
2024-04-26 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
抗Fel D1分子と動物消化物とを含むキャットフード栄養補助食品
|
WO2023212604A1
(en)
|
2022-04-27 |
2023-11-02 |
Lay Sciences, Inc. |
Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
|
WO2023220243A1
(en)
|
2022-05-13 |
2023-11-16 |
Prodigy Biotech, Inc. |
Formulations for oral delivery of polypeptides, antibodies and proteins and uses thereof
|